Skip to main content
. 2015 Nov 11;15:177. doi: 10.1186/s12887-015-0497-2

Fig. 1.

Fig. 1

Flow chart showing distribution of study subjects and medications used for KD. The numbers in parentheses denote the overall number of patients. KD: Kawasaki disease, IVIG: IntraVenous ImmunoGlobulin, IFX: Infliximab, CyA: cyclosporin, mPSL: methylprednisolone